Your fact-checks will appear here
SGLT2 inhibitors have high-quality evidence for cardiovascular and renal benefits.
Latent autoimmune diabetes in adults (LADA) lies on the diabetes spectrum between classic type 1 and type 2: it is an autoimmune, adult-onset form that initially resembles type 2 but progresses toward...
There are legitimate, FDA‑approved treatments for type 2 diabetes that have evidence of producing remission—most strongly metabolic/bariatric surgery and intentional substantial weight loss through st...
Continuous glucose monitors (CGMs) and newer glucose-lowering agents such as GLP‑1 receptor agonists and SGLT2 inhibitors promise better outcomes, but their uptake in underserved populations is constr...
A broad, evidence-based arsenal of FDA‑approved therapies exists for type 2 diabetes: lifestyle plus metformin remains the long‑standing first‑line approach, and pharmacologic options now include mult...
There is no universally accepted, one-size‑fits‑all cure for (T2D) today, but multiple pathways to sustained remission and disease modification are emerging—from metabolic surgery and intensive dietar...
Intensive, evidence-based lifestyle interventions—centering nutrition, physical activity, sleep, stress management, social support, and avoidance of risky substances—consistently improve glycemic cont...